Phapros Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Phapros Tbk. trades at Rp254 (market cap 220.08B, 204.7K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 3.4× Phapros Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 204.7K). Which is the better fit depends on your goals.
| PEHA | RSCH | |
|---|---|---|
Market Cap | 220.08B | 742B |
Volume | 204.7K | 29.45M |
Lot | 2.05K | 294.49K |
Turnover | 52.61M | 8.14B |
Average Price | 256.99 | 276.35 |
Value | 52.61M | 8.14B |
Indicative Equilibrium Price | — | 270 |
Indicative Equilibrium Volume | — | 103 |
Trailing returns across standard periods
Latest headlines on both assets
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →